Avicenna Journal of Medicine最新文献

筛选
英文 中文
Knowledge, Attitude, Awareness, and Perceptions among Physicians toward Antibiotic Resistance in Hospitals in South Palestine. 巴勒斯坦南部医院医生对抗生素耐药性的知识、态度、意识和看法
Avicenna Journal of Medicine Pub Date : 2023-01-01 DOI: 10.1055/s-0043-1764374
Hussein Jabbarin, Inad Nawajah, Hatem A Hejaz
{"title":"Knowledge, Attitude, Awareness, and Perceptions among Physicians toward Antibiotic Resistance in Hospitals in South Palestine.","authors":"Hussein Jabbarin,&nbsp;Inad Nawajah,&nbsp;Hatem A Hejaz","doi":"10.1055/s-0043-1764374","DOIUrl":"https://doi.org/10.1055/s-0043-1764374","url":null,"abstract":"<p><p><b>Background</b>  Antibiotic resistance is a global problem, and the World Health Organization has made this problem one of its priorities for solving. Therefore, a survey was carried out to investigate the knowledge, attitude, awareness, and perceptions of antibiotic resistance among physicians and to assess the correlation between the knowledge of antibiotic resistance and their years of experience in some Palestinian hospitals. <b>Methods</b>  This was a cross-sectional study that targeted physicians who are working in different healthcare facilities in Hebron and Bethlehem governorates. We used a questionnaire for data collection. The questionnaire consists of 42 questions to measure the knowledge, attitudes, awareness, and perceptions of antibiotic use and resistance. <b>Results</b>  The response rate was 91.33% (137 of 150 physicians completed the questionnaire). The participants' ages ranged from 25 to 56 years, and the majority were males ( <i>n</i>  = 116, 84.7%) working in governmental hospitals ( <i>n</i>  = 83, 60.6%). Of physicians, 69.3% ( <i>n</i>  = 95) perceived antibiotic resistance as a very important worldwide problem, while 54.7% ( <i>n</i>  = 75) perceived a very important problem in the country, 54.0% ( <i>n</i>  = 74) a very important problem in their hospital, and 59.1% ( <i>n</i>  = 81) a very important problem in their departments. Methicillin-resistant Staphylococcus aureus was the most known antibiotic-resistant bacteria followed by extended-spectrum beta-lactamases. Only 47 physicians (34.3%) think that antibiotics are not used appropriately in their department. Respondents' physicians showed that the development of antibiotic resistance was due to various factors that include self-medication n= (92, 67.2%), overuse of antibiotics ( <i>n</i>  = 83, 60.6%), and uncompleted treatment (n= 87, 63.5). Senior specialists/consultants were found to be more knowledgeable about antibiotic resistance. <b>Conclusion</b>  In our survey, physicians showed variable knowledge and perceptions of antibiotic resistance. Introducing educational programs is necessary to improve their understanding and perceptions of antibiotic resistance, as well as their attitude toward antibiotic use.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"13 1","pages":"49-55"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9245455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Thank You to All Our Reviewers in 2022 感谢所有2022年的审稿人
Avicenna Journal of Medicine Pub Date : 2023-01-01 DOI: 10.1055/s-0043-1764391
{"title":"Thank You to All Our Reviewers in 2022","authors":"","doi":"10.1055/s-0043-1764391","DOIUrl":"https://doi.org/10.1055/s-0043-1764391","url":null,"abstract":"","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"13 1","pages":"1 - 2"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43026118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Idiopathic Isolated Right Ventricular Cardiomyopathy: A Rare Case Report. 特发性孤立性右室心肌病1例报道。
Avicenna Journal of Medicine Pub Date : 2023-01-01 DOI: 10.1055/s-0043-1764376
Vivek Mohanty, Shubham Kumar Sharma, Sourabh Goswami, Rahul Gudhage, Surender Deora
{"title":"Idiopathic Isolated Right Ventricular Cardiomyopathy: A Rare Case Report.","authors":"Vivek Mohanty,&nbsp;Shubham Kumar Sharma,&nbsp;Sourabh Goswami,&nbsp;Rahul Gudhage,&nbsp;Surender Deora","doi":"10.1055/s-0043-1764376","DOIUrl":"https://doi.org/10.1055/s-0043-1764376","url":null,"abstract":"<p><p>Idiopathic isolated right ventricular cardiomyopathy is an extremely rare cause of right ventricular failure. Here, we report a case of 65-year-old male presented with chief complaints of dyspnea, fatigue, and bilateral pedal edema for the last 6 months. On clinical evaluation, grade II/III pansystolic murmur was present in left parasternal area. Investigations and imaging revealed dilated right atrium and ventricle with normal pulmonary artery pressure without any etiology. Magnetic resonance imaging ruled out other common causes of right ventricular cardiomyopathy; thus, the patient was diagnosed as a case of idiopathic isolated right ventricular cardiomyopathy that is a diagnosis of exclusion.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"13 1","pages":"56-59"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038749/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9245453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Predictive Ability of the Blood Urea Nitrogen/Albumin, C-Reactive Protein/Albumin, and Lactate/Albumin Ratios for Short-Term Mortality in SARS-CoV-2-Infected Patients. 血尿素氮/白蛋白、c反应蛋白/白蛋白和乳酸/白蛋白比值对sars - cov -2感染患者短期死亡率预测能力的比较
Avicenna Journal of Medicine Pub Date : 2023-01-01 DOI: 10.1055/s-0043-1761471
Serdar Özdemir, İbrahim Altunok
{"title":"Comparison of the Predictive Ability of the Blood Urea Nitrogen/Albumin, C-Reactive Protein/Albumin, and Lactate/Albumin Ratios for Short-Term Mortality in SARS-CoV-2-Infected Patients.","authors":"Serdar Özdemir,&nbsp;İbrahim Altunok","doi":"10.1055/s-0043-1761471","DOIUrl":"https://doi.org/10.1055/s-0043-1761471","url":null,"abstract":"<p><p><b>Background</b>  Hematological parameters and their ratios are the most studied biomarkers for prediction of mortality or severe illness in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aims to compare the power of the blood urea nitrogen (BUN)/albumin ratio, lactate/albumin ratio, and C-reactive protein (CRP)/albumin ratio, measured at the time of admission, in predicting 30-day mortality in SARS-CoV-2-infected patients presenting to the emergency department (ED). <b>Materials and Methods</b>  This retrospectively designed, single-center, observational study was performed in the ED of a tertiary education health care center. We documented the data of patients admitted with a confirmed SARS-CoV-2 infection between September 1, 2020, and January 1, 2021. <b>Results</b>  Of the 470 patients included in the study, 232 (49.4%) were female. The all-cause 30-day mortality rate was 23.8%. The area under the curve values for the BUN/albumin ratio, lactate/albumin ratio, and CRP/albumin ratio in the prediction of 30-day mortality were 0.725, 0.641, and 0.749, respectively. Sensitivity and negative predictive value for CRP/albumin ratio (≥0.049) and specificity for BUN/albumin ratio (≥1.17) were 92.86, 94.9, and 71.23, respectively. The odds ratio values of the BUN/albumin ratio (≥1.17), CRP/albumin ratio (≥0.049), and lactate/albumin ratio (≥0.046) for 30-day mortality were determined as 4.886, 9.268, and 2.518, respectively. <b>Conclusion</b>  The BUN/albumin ratio and CRP/albumin ratio can be used to predict 30-day mortality in SARS-CoV-2-infected patients admitted to ED. Furthermore, CRP/albumin ratio had the highest sensitivity and negative predictive value, while BUN/albumin ratio had the highest specificity.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"13 1","pages":"43-48"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038752/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10288574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Pneumocystis jiroveci Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients. 乙型肺囊虫肺炎:人类免疫缺陷病毒(HIV)和非HIV免疫低下患者的管理综述。
Avicenna Journal of Medicine Pub Date : 2023-01-01 DOI: 10.1055/s-0043-1764375
Atif Ibrahim, Asmi Chattaraj, Qamar Iqbal, Ali Anjum, Mohammad Ebad Ur Rehman, Zobia Aijaz, Fazila Nasir, Sadia Ansar, Tirdad T Zangeneh, Ahmad Iftikhar
{"title":"<i>Pneumocystis jiroveci</i> Pneumonia: A Review of Management in Human Immunodeficiency Virus (HIV) and Non-HIV Immunocompromised Patients.","authors":"Atif Ibrahim,&nbsp;Asmi Chattaraj,&nbsp;Qamar Iqbal,&nbsp;Ali Anjum,&nbsp;Mohammad Ebad Ur Rehman,&nbsp;Zobia Aijaz,&nbsp;Fazila Nasir,&nbsp;Sadia Ansar,&nbsp;Tirdad T Zangeneh,&nbsp;Ahmad Iftikhar","doi":"10.1055/s-0043-1764375","DOIUrl":"https://doi.org/10.1055/s-0043-1764375","url":null,"abstract":"<p><p><i>Pneumocystis jirovecii</i> pneumonia is an opportunistic fungal infection that was mainly associated with pneumonia in patients with advanced human immunodeficiency virus (HIV) disease. There has been a decline in <i>Pneumocystis jirovecii</i> pneumonia incidence in HIV since the introduction of antiretroviral medications. However, its incidence is increasing in non-HIV immunocompromised patients including those with solid organ transplantation, hematopoietic stem cell transplantation, solid organ tumors, autoimmune deficiencies, and primary immunodeficiency disorders. We aim to review and summarize the etiology, epidemiology, clinical presentation, diagnosis, and management of <i>Pneumocystis jirovecii</i> pneumonia in HIV, and non-HIV patients. HIV patients usually have mild-to-severe symptoms, while non-HIV patients present with a rapidly progressing disease. Induced sputum or bronchoalveolar lavage fluid can be used to make a definitive diagnosis of <i>Pneumocystis jirovecii</i> pneumonia. Trimethoprim-sulfamethoxazole is considered to be the first-line drug for treatment and has proven to be highly effective for <i>Pneumocystis jirovecii</i> pneumonia prophylaxis in both HIV and non-HIV patients. Pentamidine, atovaquone, clindamycin, and primaquine are used as second-line agents. While several diagnostic tests, treatments, and prophylactic regimes are available at our disposal, there is need for more research to prevent and manage this disease more effectively.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"13 1","pages":"23-34"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038753/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9193253","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 Ramifications: A Scientific Approach to Bridge the Existing Gap between COVID Vaccines Hesitancy and Effectiveness. COVID-19后果:弥合COVID疫苗犹豫与有效性之间现有差距的科学方法
Avicenna Journal of Medicine Pub Date : 2023-01-01 DOI: 10.1055/s-0042-1760338
Hassan Nagy, Maha Hameed, Faryal Khan, Edzel Lorraine Co, Unaiza Rauf
{"title":"COVID-19 Ramifications: A Scientific Approach to Bridge the Existing Gap between COVID Vaccines Hesitancy and Effectiveness.","authors":"Hassan Nagy,&nbsp;Maha Hameed,&nbsp;Faryal Khan,&nbsp;Edzel Lorraine Co,&nbsp;Unaiza Rauf","doi":"10.1055/s-0042-1760338","DOIUrl":"https://doi.org/10.1055/s-0042-1760338","url":null,"abstract":"<p><p>The 2019 coronavirus disease (COVID-19) has been a major dilemma all over the world since December 2019. Several types of COVID-19 vaccines were developed for public utilization to halt the widespread of the disease; however, vaccine hesitancy is one major factor that prevents a successful control of this pandemic. This study aimed to summarize the different kinds of available COVID-19 vaccines and their effectiveness, and to assess the associated factors regarding vaccine hesitancy of the general population to bridge the gap existing between the two factors. 1 3.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"13 1","pages":"15-22"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038754/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10217955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aldosterone-Secreting Large Oncocytic Neoplasm of the Adrenal Gland with Borderline Potential. 肾上腺边缘电位分泌醛固酮的大嗜瘤细胞瘤。
Avicenna Journal of Medicine Pub Date : 2022-10-01 DOI: 10.1055/s-0042-1756675
Maher Alshaheen, Krishanu Das, Mary Jean, Mhd Firas Safadi
{"title":"Aldosterone-Secreting Large Oncocytic Neoplasm of the Adrenal Gland with Borderline Potential.","authors":"Maher Alshaheen,&nbsp;Krishanu Das,&nbsp;Mary Jean,&nbsp;Mhd Firas Safadi","doi":"10.1055/s-0042-1756675","DOIUrl":"https://doi.org/10.1055/s-0042-1756675","url":null,"abstract":"<p><p>Adrenal oncocytomas are rare tumors that are mostly benign and non-functional although they may be hormonally active and can exhibit a borderline or malignant potential. We present a case of a 40-year-old female patient with known hypertension who presented with abdominal discomfort. Radiologic investigations showed a large mass on the left adrenal gland. In the hormonal study, an aldosterone-secreting tumor was identified. After laparoscopic resection, the histological assessment of the 12-cm mass showed an oncocytic neoplasm with borderline characteristics. The laboratory results returned to normal and the hypertensive disease improved. The patient was doing well after 14 months of follow-up. This is the seventh documented case of aldosterone-secreting oncocytoma, the first borderline tumor of this type, and the largest reported tumor so far.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"12 4","pages":"182-185"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/de/10-1055-s-0042-1756675.PMC9771619.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10786838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Vesical Imaging-Reporting and Data System in Evaluation of Urinary Bladder Cancer Using Multiparametric Magnetic Resonance Imaging: A Hospital-Based Cross-Sectional Study. 膀胱影像报告与数据系统在多参数磁共振评价膀胱癌中的应用:一项基于医院的横断面研究。
Avicenna Journal of Medicine Pub Date : 2022-10-01 DOI: 10.1055/s-0042-1755334
Rahul Gupta, Manik Mahajan, Poonam Sharma, Subhash Bhardwaj, Vikrant Gupta, Arti Mahajan
{"title":"Application of Vesical Imaging-Reporting and Data System in Evaluation of Urinary Bladder Cancer Using Multiparametric Magnetic Resonance Imaging: A Hospital-Based Cross-Sectional Study.","authors":"Rahul Gupta,&nbsp;Manik Mahajan,&nbsp;Poonam Sharma,&nbsp;Subhash Bhardwaj,&nbsp;Vikrant Gupta,&nbsp;Arti Mahajan","doi":"10.1055/s-0042-1755334","DOIUrl":"https://doi.org/10.1055/s-0042-1755334","url":null,"abstract":"<p><p><b>Background</b>  Multiparametric magnetic resonance imaging (mp-MRI) of urinary bladder (UB) is a novel imaging to predict detrusor muscle invasion in Bladder cancer (BC). The Vesical Imaging-Reporting and Data System (VI-RADS) was introduced in 2018 to standardize the reporting of BC with mp-MRI and to diagnose muscle invasion. This study was performed to evaluate the role of mp-MRI using VI-RADS to predict muscle invasive BC. <b>Methods</b>  This prospective study was carried from June 2020 to May 2021 in a tertiary care institute. Thirty-six patients with untreated BC underwent mp-MRI followed by transuretheral resection of the tumor (TURBT). Mp-MRI findings were evaluated by two radiologists and BC was categorized according to VI-RADS scoring system. Resected tumors along with separate biopsy from the base were reported by two pathologists. Histopathological findings were compared with VI-RADS score and the performance of VI-RADS for determining detrusor muscle invasion was analyzed. <b>Results</b>  VI-RADS scores of 4 and 5 were assigned to 9 (25%) and 15 (41.7%) cases, respectively, while 4 (13.3%) cases had VI-RADS score 3 on mp-MRI. VI-RADS 1 and 2 lesions were observed in six (16.7%) and two (5.5%) cases, respectively. On histopathology, 23 cases (63.9%) had muscle-invasive cancer and 13 cases (36.1%) had non-muscle-invasive cancer. The sensitivity and diagnostic accuracy of mp-MRI in predicting muscle invasive BC was 95.6 and 80.6%, respectively. <b>Conclusion</b>  Mp-MRI has high sensitivity and diagnostic accuracy in predicting muscle invasive BC and should be advocated for evaluation of BC prior to surgery.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"12 4","pages":"162-168"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/18/31/10-1055-s-0042-1755334.PMC9771629.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10804798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cancer Diagnoses during Active Conflict: Experience from a Cancer Program in Northwest Syria. 冲突期间的癌症诊断:来自叙利亚西北部癌症项目的经验。
Avicenna Journal of Medicine Pub Date : 2022-10-01 DOI: 10.1055/s-0042-1755331
Bassel Atassi, Gina Tse, Hala Mkhallalati, Jamil Debel, Ayham Jemmo, Molham Khalil, Yahya Alrahal, Monzr Almalki, Mufaddal Hamadeh, Ahmad Tarakji, Aula Abbara
{"title":"Cancer Diagnoses during Active Conflict: Experience from a Cancer Program in Northwest Syria.","authors":"Bassel Atassi,&nbsp;Gina Tse,&nbsp;Hala Mkhallalati,&nbsp;Jamil Debel,&nbsp;Ayham Jemmo,&nbsp;Molham Khalil,&nbsp;Yahya Alrahal,&nbsp;Monzr Almalki,&nbsp;Mufaddal Hamadeh,&nbsp;Ahmad Tarakji,&nbsp;Aula Abbara","doi":"10.1055/s-0042-1755331","DOIUrl":"https://doi.org/10.1055/s-0042-1755331","url":null,"abstract":"<p><p><b>Background</b>  Protracted conflict has destroyed Syria's health system with severe impacts on the diagnosis and treatment of chronic and high-cost diseases including cancer. Here, we review the type and (where possible) the stage of cancers diagnosed in a pathology laboratory serving Northwest Syria. <b>Methods</b>  We retrospectively reviewed all pathology reports which reported a diagnosis of cancer from a pathology department in Northwest Syria from January to December 2020. <b>Results</b>  A total of 397 new cancers were diagnosed during 2020 of which 191 were among males (48.1%) and 20 cases were in children aged 17 years or under (5%). The most common cancer in men was bladder cancer (15.7%) and skin cancers (14.7%) followed by cancers in the lymph nodes (includes primary and secondary; 9.9%.) In women, breast cancer (38.3%) followed by skin cancer skin (9.7%) and uterine cancer (8.7%) was the most common. The overall proportion of cancer diagnoses were breast cancer (20.2%), skin cancer (12.1%), cancer affecting lymph nodes (8.8%), and urinary bladder (8.3%) and colorectal cancer (7.3%). <b>Discussion</b>  This preliminary analysis is the first report of cancer types and demographics in areas outside of government control in Syria since the onset of the conflict. Despite limitations, it presents some indication of the burden of oncological diagnoses in this area. Further research which aims to describe and address the burden of cancer on populations under ongoing conflict and humanitarian crises remains essential, especially in Northwest Syria given ongoing attacks and severe underfunding. There is a particular need to investigate how best to apply interventions and support health systems and cancer services within conflict settings. More support and resources need to be allocated to cancer centers with long-term health partnership models. The underresourced and understaffed conditions of the hospital are significant limits to a more detailed report.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"12 4","pages":"157-161"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/20/b2/10-1055-s-0042-1755331.PMC9771609.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10804797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Comparison of EMLA Cream versus Lidocaine Injection for Lumbar Puncture Pain Control in Pediatric Oncology Patients. EMLA乳膏与利多卡因在小儿肿瘤患者腰椎穿刺疼痛控制中的比较。
Avicenna Journal of Medicine Pub Date : 2022-10-01 DOI: 10.1055/s-0042-1758389
Andrea D Merry-Sperry, Elham Alqudah, Alexa Magner, Stephanie Thompson, Pamela Smith, Ashley Meyer, Mohamad Badawi
{"title":"Comparison of EMLA Cream versus Lidocaine Injection for Lumbar Puncture Pain Control in Pediatric Oncology Patients.","authors":"Andrea D Merry-Sperry,&nbsp;Elham Alqudah,&nbsp;Alexa Magner,&nbsp;Stephanie Thompson,&nbsp;Pamela Smith,&nbsp;Ashley Meyer,&nbsp;Mohamad Badawi","doi":"10.1055/s-0042-1758389","DOIUrl":"https://doi.org/10.1055/s-0042-1758389","url":null,"abstract":"<p><p><b>Background</b>  Subcutaneous lidocaine injection and topical EMLA cream are both used to control lumbar puncture (LP) pain; however, local analgesia usage is not standardized. <b>Methods</b>  We conducted a prospective, single-blinded, randomized-controlled crossover trial comparing the two modalities in reducing LP pain. Pediatric patients requiring serial LPs were randomly assigned to receive EMLA cream or lidocaine injection prior to LP. On the subsequent LP, analgesia was defaulted to the other agent. Pain was assessed using the Wong-Baker FACES Pain Rating Scale pre-procedure: 30 to 60 minutes post-LP, and 24 hours post-procedure. <b>Results</b>  Ten patients were included in the analysis (median age: 5.5 years). Pain ratings at 1 and 24 hours post-LP did not differ between the two strategies ( <i>p</i>  = 0.79). No adverse local reactions were reported for either agent. <b>Conclusion</b>  Accordingly, both lidocaine and EMLA cream provided effective LP pain control.</p>","PeriodicalId":32889,"journal":{"name":"Avicenna Journal of Medicine","volume":"12 4","pages":"178-181"},"PeriodicalIF":0.0,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/ad/10-1055-s-0042-1758389.PMC9771623.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10804796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信